Cytomegalovirus viremia: Risk factor for allograft cirrhosis after liver transplantation for hepatitis C

Transplantation

Volumn 64, Issue 5, 1997, Pages 721-726

  Rosen, Hugo R ^a   Chou, Sunwen ^a   Corless, Christopher L ^a   Gretch, David R ^b   Flora, Kenneth D ^a   Boudousquie, Alan ^a   Orloff, Susan L ^a   Rabkin, John M ^a   Benner, Kent G ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; GLYCOPROTEIN;

ADULT; ALLOGRAFT; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GRAFT REJECTION; HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; VIREMIA;

ANTIVIRAL AGENTS; BIOPSY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; GENOTYPE; GRAFT REJECTION; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MIDDLE AGED; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030985417     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199709150-00010     Document Type: Article

References (44)

1. Patel R, Snydman DR, Rubin RH, et al. Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation 1996; 61: 1279.
2. Van den Berg AP, Van Son WJ, Haagsma EB, et al. Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients. Transplantation 1993; 55: 847.
3. Leach CT, Detels R, Hennessey K, et al. A longitudinal study of cytomegalovirus infection in human immunodeficiency virus type 1-seropositive homosexual men: molecular epidemiology and association with disease progression. J Infect Dis 1994; 170: 293.
4. Webster A, Lee CA, Cook DG, et al. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet 1989; 2: 63.
5. Stratta RJ, Shaeffer MS, Markin RS, et al. Cytomegalovirus infection and disease after liver transplantation. Dig Dis Sci 1992; 37: 673.
6. Wiesner RH, Marin E, Porayko MK, Steers JL, Krom RAF, Paya CV. Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation. Gastroenterol Clin North Am 1993; 22: 351.
7. Rook AH. Interactions of cytomegalovirus with the human immune system. Rev Infect Dis 1988; 10 (suppl 3): S460.
8. Kowalik TF, Wing B, Haskill JS, Azizkhan JC, Baldwin AS, Huang ES. Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Immunology 1993; 78: 405.
9. Rosen HR, O'Reilly PM, Shackleton CR, et al. Graft loss following liver transplantation in patients with chronic hepatitis C. Transplantation 1996; 62: 1773.
10. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815.
11. Gane EJ, Naoumov NK, Qian KP, et al. A longitudinal analysis of hepatitis C replication following liver transplantation. Gastroenterology 1996; 110: 167.
12. Gretch DR, Polyak SJ, Wilson JJ, Carithers RL, Perkins JD, Corey L. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol 1996; 70: 7622.
13. Sheiner PA, Schwartz ME, Mor E, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995; 21: 30.
14. Gretch DR, Lee W, Corey L. Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory. J Clin Microbiol 1992; 30: 2145.
15. Davidson F, Simmonds P, Ferguson JC, et al. Survey of major genotypes and subtypes of hepatitis C using RFLP of sequences amplified from the 5′ noncoding region. J Gen Virol 1995; 76: 1197.
16. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74: 2391.
17. Chou S, Dennison KM. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 1991; 163: 1229.
18. Chou S. Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus. J Infect Dis 1992; 166: 604.
19. Fries BC, Chou S, Boeckh M, Torok-Storb B. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 1994; 169: 769.
20. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 5: 431.
21. DiBisceglie AM. Liver transplantation for hepatitis C: the promise and the challenge. Hepatology 1995; 22: 660.
22. Chazouillerees O, Kim M, Mamish D, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994; 106: 994.
23. Rosen HR, Shackleton CR, Higa L, et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol 1997; 92(9): 1453.
24. Rosen HR, Martin P. OKT3 and hepatitis C: defining the risks. Transplantation 1997; 63: 171.
25. Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994; 331: 1607.
26. Martin P, DiBisceglie AD, Kassiandes C, Lisker-Melmav M, Hoofnagle J. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 1989; 97: 1559.
27. DiMartino V, Rufat P, Martinot M, et al. Influence of HIV infection on the outcome of chronic hepatitis C. Hepatology 1996; 24: 382A.
28. Walter EA, Greenberg PD, Gilbert MJ, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995; 333: 1038.
29. Gehrz RC, Liu YNC, Eckhardt J, Klaus A. Relevance of immune responses to pathogenesis of cytomegalovirus-associated diseases. Transplant Proc 1991; 23: 75.
30. 2 in human monocytes. J Clin Invest 1996; 97: 2635.
31. Larrea E, Garcia N, Qian C, Civeira MP, Prieto J. Tumor necrosis factor-alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology 1996; 23: 210.
32. Levy G. Hepatitis C: diagnosis and treatment. ILTS postgraduate course: Recurrent liver disease after liver transplantation. Chicago, November 8, 1996.
33. Funinami RS, Nelson JA, Walker L, Oldstone MB. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J Virol 1988; 62: 100.
34. Rubin RH. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA 1989; 261: 3607.
35. Mosnier J-F, Scoazec J-Y, Marcellin P, et al. Expression of cytokine-dependent immune adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C. Gastroenterology 1994; 107: 1457.
36. Cai WH, Gu B, Person S. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J Virol 1988; 62: 2596.
37. Zhou S, Terrault NA, Ferrell L, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 1996; 24: 1041.
38. Vargas H, Wang L, Laskus T, et al. Infecting HCV genotypes: a final report on HCV genotype influence on the outcome of liver transplantation for HCV-related end-stage liver disease. Hepatology 1996; 24: 182A.
39. Mutimer D, Matyi-Toth A, Elias E, et al. Quantitation of cytomegalovirus in blood of liver transplant recipients. Liver Transpl Surg 1995; 1: 395.
40. Delgado R, Lumbreras C, Alba C, et al. Low predictive value of polymerase chain reaction for diagnosis of CMV disease in liver transplant recipients. J Clin Microbiol 1992; 30: 1876.
41. Schmidt CA, Oettle H, Peng R, et al. Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation. Transplantation 1995; 59: 1133.
42. Patel R, Smith TF, Espy M, et al. A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J Infect Dis 1995; 171: 1010.
43. Drouet E, Colimon R, Michelson S, et al. Monitoring levels of human cytomegalovirus DNA in blood after liver transplantation. J Clin Microbiol 1995; 33: 389.
44. Rosen HR, Benner KG, Flora KD, et al. Development of ganciclovir resistance during treatment of primary cytomegalovirus infection following liver transplantation. Transplantation 1997; 63: 476.